Assenagon Asset Management S.A. lifted its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 9.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 344,204 shares of the health services provider’s stock after purchasing an additional 29,874 shares during the quarter. Assenagon Asset Management S.A. owned about 0.13% of Cigna Group worth $94,735,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of the business. Brighton Jones LLC raised its holdings in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC boosted its holdings in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. Magnetar Financial LLC acquired a new position in Cigna Group in the 2nd quarter valued at about $724,000. Charles Schwab Investment Management Inc. grew its position in Cigna Group by 0.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 2,052,912 shares of the health services provider’s stock valued at $678,652,000 after acquiring an additional 15,014 shares in the last quarter. Finally, Coldstream Capital Management Inc. increased its stake in Cigna Group by 3.5% during the second quarter. Coldstream Capital Management Inc. now owns 6,208 shares of the health services provider’s stock worth $2,052,000 after purchasing an additional 208 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by insiders.
Cigna Group Stock Down 0.4%
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period last year, the firm posted $6.64 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date was Thursday, March 5th. Cigna Group’s payout ratio is presently 28.13%.
Analysts Set New Price Targets
CI has been the topic of a number of research reports. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $307.00 to $358.00 in a report on Thursday, March 12th. Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Royal Bank Of Canada reduced their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. TD Cowen lifted their target price on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. Finally, Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $333.11.
Read Our Latest Research Report on Cigna Group
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
